Alector Inc (ALEC)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $378.15M
Last updated: Nov 17, 2026 at 11:04 AM ET
Alector Inc (ALEC) Financials: Revenue, Profit and Cash Flow
Alector reported revenue of $21.05M for the fiscal year ended Dec 31, 2025, down 79.1% from the year before. That year, net income was -$142.93M with a net margin of -679.2%, operating cash flow was -$184.03M and free cash flow was -$184.07M. The quarter ended Sep 30, 2026 had revenue of $162.87M and net income of $124.60M.
Revenue and Margins
Over the 9 years to Dec 2025, revenue grew from $416.00K, a compound annual rate of 54.7%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $21.05M | -79.1% | 100.0% | -741.3% | -679.2% |
| Dec 2024 | $100.56M | +3.6% | 100.0% | -144.2% | -118.4% |
| Dec 2023 | $97.06M | -27.4% | 100.0% | -156.3% | -134.3% |
| Dec 2022 | $133.62M | -35.5% | 100.0% | -103.2% | -99.8% |
| Dec 2021 | $207.09M | +881.5% | 100.0% | -18.0% | -17.5% |
| Dec 2020 | $21.10M | N/A | 100.0% | -925.1% | -901.6% |
| Dec 2019 | $0 | -100.0% | N/A | N/A | N/A |
| Dec 2018 | $27.68M | +641.0% | 100.0% | -207.0% | -188.8% |
| Dec 2017 | $3.73M | +797.8% | 100.0% | -874.9% | -869.6% |
| Dec 2016 | $416.00K | N/A | -3187.0% | -3637.5% | -3632.2% |
Income Statement
In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Sep 2026, net income turned positive after a loss in the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $21.05M | $100.56M | $97.06M | $133.62M | $207.09M | $21.10M | $0 | $27.68M | $3.73M | $416.00K |
| Cost of revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $13.67M |
| Gross profit | $21.05M | $100.56M | $97.06M | $133.62M | $207.09M | $21.10M | $21.22M | $27.68M | $3.73M | -$13.26M |
| Research and development | $123.06M | $185.94M | $192.12M | $210.42M | $189.41M | $156.87M | $100.53M | $73.03M | $29.91M | $13.67M |
| Operating income | -$156.01M | -$145.00M | -$151.74M | -$137.83M | -$37.36M | -$195.17M | -$114.40M | -$57.29M | -$32.68M | -$15.13M |
| Net income | -$142.93M | -$119.05M | -$130.39M | -$133.31M | -$36.33M | -$190.23M | -$105.39M | -$52.25M | -$32.48M | -$15.11M |
| EBITDA | -$139.39M | -$124.46M | -$131.65M | -$122.75M | -$25.91M | -$182.38M | -$104.51M | -$53.97M | -$31.80M | -$14.93M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $162.87M | $3.32M | $1.05M | $6.24M | $3.26M | $7.87M | $3.67M | $54.24M | $15.34M | $15.08M | $15.89M | $15.19M |
| Gross profit | $162.87M | $3.32M | $1.05M | $6.24M | $3.26M | $7.87M | $3.67M | $54.24M | $15.34M | $15.08M | $15.89M | $15.19M |
| Operating income | $123.84M | -$24.39M | -$24.92M | -$39.57M | -$37.61M | -$34.14M | -$44.70M | -$7.25M | -$48.43M | -$45.61M | -$43.71M | -$47.45M |
| Net income | $124.60M | -$22.99M | -$22.93M | -$37.27M | -$34.67M | -$30.52M | -$40.47M | -$2.07M | -$42.22M | -$38.68M | -$36.08M | -$41.43M |
Balance Sheet
As of Dec 2025, cash and equivalents exceeded total debt of $9.69M by $56.11M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $293.24M | $468.30M | $621.83M | $787.65M | $814.66M | $488.25M | $421.91M | $308.36M | $236.06M | $54.11M |
| Current assets | $266.45M | $424.82M | $565.81M | $726.43M | $749.71M | $421.51M | $357.44M | $293.18M | $232.97M | $51.19M |
| Cash and equivalents | $65.80M | $33.02M | $74.56M | $154.32M | $329.15M | $49.97M | $89.64M | $65.47M | $32.45M | $50.84M |
| Total liabilities | $262.59M | $341.50M | $487.67M | $573.21M | $513.93M | $220.72M | $227.17M | $195.24M | $288.09M | $79.02M |
| Short-term debt | $366.00K | $0 | $8.46M | $8.06M | $7.79M | $7.51M | $6.57M | $34.91M | N/A | N/A |
| Long-term debt | $9.32M | $9.39M | $0 | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Shareholder equity | $30.65M | $126.80M | $134.16M | $214.44M | $300.72M | $267.53M | $194.74M | -$97.40M | -$52.03M | -$24.91M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $165.78M | $202.85M | $239.92M | $293.24M | $335.29M | $356.42M | $408.30M | $468.30M | $516.02M | $570.73M | $635.49M | $621.83M |
| Total liabilities | $49.21M | $212.82M | $229.53M | $262.59M | $277.57M | $285.25M | $313.69M | $341.50M | $397.09M | $420.16M | $456.59M | $487.67M |
| Cash and equivalents | $75.47M | $59.91M | $76.96M | $65.80M | $76.50M | $44.77M | $37.97M | $33.02M | $37.16M | $47.55M | $72.55M | $74.56M |
| Shareholder equity | $116.57M | -$9.97M | $10.38M | $30.65M | $57.71M | $71.17M | $94.61M | $126.80M | $118.93M | $150.57M | $178.91M | $134.16M |
Cash Flow
Operating cash flow was negative in the fiscal year ended Dec 2025.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$184.03M | -$229.91M | -$184.16M | -$20.33M | $298.55M | -$166.73M | -$99.31M | $127.46M | -$17.77M | -$12.99M |
| Capital expenditures | $41.00K | $1.25M | $2.38M | $4.12M | $3.25M | $5.03M | $15.27M | $1.88M | $801.00K | $2.25M |
| Free cash flow | -$184.07M | -$231.16M | -$186.54M | -$24.45M | $295.30M | -$171.77M | -$114.57M | $125.58M | -$18.57M | -$15.24M |
| Investing cash flow | $196.60M | $107.13M | $101.92M | -$159.01M | -$49.66M | -$105.05M | -$48.87M | -$224.12M | -$801.00K | -$2.25M |
| Financing cash flow | $20.21M | $81.54M | $2.55M | $4.51M | $30.30M | $232.11M | $172.35M | $131.15M | -$15.00K | -$77.00K |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$24.15M | -$34.22M | -$49.81M | -$41.69M | -$32.51M | -$49.05M | -$60.78M | -$55.03M | -$50.73M | -$62.80M | -$61.35M | -$46.07M |
| Capital expenditures | N/A | $31.00K | $118.00K | $0 | $11.00K | $10.00K | $20.00K | $173.00K | $212.00K | $337.00K | $533.00K | $233.00K |
| Free cash flow | N/A | -$34.25M | -$49.93M | -$41.69M | -$32.52M | -$49.06M | -$60.80M | -$55.20M | -$50.95M | -$63.13M | -$61.88M | -$46.30M |
Frequently Asked Questions About ALEC
What is Alector's annual revenue?
Alector reported revenue of $21.05M for the fiscal year ended Dec 31, 2025.
How fast is Alector's revenue growing?
Revenue was down 79.1% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -46.0%.
Is Alector profitable?
No. Alector reported net income of -$142.93M for the fiscal year ended Dec 31, 2025, with a net margin of -679.2%.
How much free cash flow does ALEC generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of -$184.03M minus capital expenditures of $41.00K produced free cash flow of -$184.07M.
How much debt does Alector have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $9.32M, short-term debt of $366.00K and cash and equivalents of $65.80M.
ALEC pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors